597
Views
0
CrossRef citations to date
0
Altmetric
Articles

Role of corticotropin-releasing hormone receptor 1 in the regulation of nociception in mice

, , , &
Pages 304-310 | Received 29 May 2014, Accepted 14 Sep 2014, Published online: 29 Oct 2014

References

  • Aguilera G, Nikodemova M, Wynn PC, Catt KJ. 2004. Corticotropin releasing hormone receptors: two decades later. Peptides. 25:319–329.10.1016/j.peptides.2004.02.002
  • Ayesta FJ, Nikolarakis KE. 1989. Peripheral but not intracerebroventricular corticotropin-releasing hormone (CRH) produces antinociception which is not opioid mediated. Brain Res. 503:219–224.10.1016/0006-8993(89)91667-3
  • Bale TL. 2005. Sensitivity to stress: dysregulation of CRF pathways and disease development. Horm Behav. 48:1–10.10.1016/j.yhbeh.2005.01.009
  • Bourbia N, Ansah OB, Pertovaara A. 2010. Corticotropin-releasing factor in the rat amygdala differentially influences sensory-discriminative and emotional-like pain response in peripheral neuropathy. J Pain. 11:1461–1471.10.1016/j.jpain.2010.05.004
  • Chen RP, Lewis KA, Perrin MH, Vale WW. 1993. Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA. 90:8967–8971.10.1073/pnas.90.19.8967
  • Choi SS, Han KJ, Lee JK, Lee HK, Han EJ, Kim DH, Suh HW. 2003. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci. 73:471–485.10.1016/S0024-3205(03)00311-4
  • Choi SS, Han EJ, Lee TH, Lee JK, Han KJ, Lee HK, Suh HW. 2002. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse. Planta Med. 68:794–798.10.1055/s-2002-34396
  • Choi SS, Lee JK, Suh HW. 2001. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res. 921:233–239.10.1016/S0006-8993(01)03126-2
  • Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156–159. 10.1016/0003-2697(87)90021-2
  • Chrousos GP, Gold PW. 1992. The concepts of stress and stress system disorders overview of physical and behavioral homeostasis. JAMA. 267:1244–1252.10.1001/jama.1992.03480090092034
  • Dautzenberg FM, Hauger RL. 2002. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci. 23:71–77.10.1016/S0165-6147(02)01946-6
  • del Rey A, Yau HJ, Randolf A, Centeno MV, Wildmann J, Martina M, Besedovsky HO, Apkarian AV. 2011. Chronic neuropathic pain-like behavior correlates with IL-1β expression and disrupts cytokine interactions in the hippocampus. Pain. 152:2827–2835.10.1016/j.pain.2011.09.013
  • Duric V, McCarson KE. 2007. Neurokinin-1 (NK-1) receptor and brain-derived neurotrophic factor (BDNF) gene expression is differentially modulated in the rat spinal dorsal horn and hippocampus during inflammatory pain. Mol Pain. 3:32.10.1186/1744-8069-3-32
  • Fu Y, Neugebauer V. 2008. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci. 28:3861–3876.10.1523/JNEUROSCI.0227-08.2008
  • Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. 2003. International union of pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropinreleasing factor and their ligands. Pharmacol Rev. 55:21–26.10.1124/pr.55.1.3
  • Hunskaar S, Fasmer OB. Hole K. 1985. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods. 14:69–76.10.1016/0165-0270(85)90116-5
  • Hunskaar S, Hole K. 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 30:103–114.10.1016/0304-3959(87)90088-1
  • Hylden JL, Wilcox GL. 1981. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res. 217:212–215.10.1016/0006-8993(81)90203-1
  • Ji G, Neugebauer V. 2008. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. J Neurophysiol. 99:1201–1212.10.1152/jn.01148.2007
  • Kwon MS, Seo YJ, Shim EJ, Lee JK, Jang JE, Park SH, Jung JS, Suh HW. 2008. The differential effects of emotional or physical stress on pain behaviors or on c-Fos immunoreactivity in paraventricular nucleus or arcuate nucleus. Brain Res. 1190:122–131.10.1016/j.brainres.2007.11.009
  • Lariviere WR, Fiorenzani P, Ceccarelli I, Massafra C, Sorda G, Di Canio C, Aloisi AM. 2011. Central CRH administration changes formalin pain responses in male and female rats. Brain Res. 1383:128–134.10.1016/j.brainres.2011.01.106
  • Lariviere WR, Melzack R. 2000. The role of corticotropin-releasing factor in pain and analgesia. Pain. 84:1–12.10.1016/S0304-3959(99)00193-1
  • Liao XM, Yang XD, Jia J, Li JT, Xie XM, Su YA, Schmidt MV, Si TM, Wang XD. 2014. Blockade of corticotropin-releasing hormone receptor 1 attenuates early-life stress-induced synaptic abnormalities in the neonatal hippocampus. Hippocampus. 24:528–540.10.1002/hipo.22254
  • Lowery EG, Spanos M, Navarro M, Lyons AM, Hodge CW, Thiele TE. 2010. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacol. 35:1241–1252.10.1038/npp.2009.209
  • Miguel TT, Nunes-de-Souza RL. 2011. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice. Horm Behav. 60:292–300.10.1016/j.yhbeh.2011.06.004
  • Neugebauer V, Li W, Bird GC, Han JS. 2004. The amygdala and persistent pain. Neuroscientist. 10:221–234.10.1177/1073858403261077
  • Nishii H, Nomura M, Aono H, Fujimoto N, Matsumoto T. 2007. Up-regulation of galanin and corticotropin-releasing hormone mRNAs in the key hypothalamic and amygdaloid nuclei in a mouse model of visceral pain. Regul Pept. 141:105–112.10.1016/j.regpep.2006.12.022
  • Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, Dedic N, Schumacher M, von Wolff G, Avrabos C, et al. 2011. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science. 333:1903–1907.10.1126/science.1202107
  • Schierloh A, Deussing J, Wurst W, Zieglgänsberger W, Rammes G. 2007. Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity. Neurosci Lett. 416:82–86.10.1016/j.neulet.2007.01.047
  • Seo YJ, Kwon MS, Choi SS, Han EJ, Jung JS, Choi HW, Park SH, Jang JE, Suh HW. 2008. Characterization of the hypothalamic proopiomelanocortin gene and beta-endorphin expression in the hypothalamic arcuate nucleus of mice elicited by inflammatory pain. Neuroscience. 152:1054–1066.10.1016/j.neuroscience.2007.06.047
  • Sherman JE, Kalin NH. 1986. ICV-CRH potently affects behavior without altering antinociceptive responding. Life Sci. 39:433–441.10.1016/0024-3205(86)90523-0
  • Taché Y, Million M, Nelson AG, Lamy C, Wang L. 2005. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med. 2:146–154.10.1016/S1550-8579(05)80043-9
  • Thoeringer CK, Henes K, Eder M, Dahlhoff M, Wurst W, Holsboer F, Deussing JM, Moosmang S, Wotjak CT. 2011. Consolidation of remote fear memories involves Corticotropin-Releasing Hormone (CRH) receptor type 1-mediated enhancement of AMPA receptor GluR1 signaling in the dentate gyrus. Neuropsychopharmacol. 37:787–796.10.1038/npp.2011.256
  • Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W. 1998. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet. 19:162–166.10.1038/520
  • Vit JP, Clauw DJ, Moallem T, Boudah A, Ohara PT, Jasmin L. 2006. Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats. Pain. 121:241–260.10.1016/j.pain.2005.12.024

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.